Sumit Aggarwal
2022
In 2022, Sumit Aggarwal earned a total compensation of $1.4M as Chief Executive Officer at Sevion Therapeutics, a 75% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $253,022 |
|---|---|
| Option Awards | $556,270 |
| Salary | $575,050 |
| Other | $11,600 |
| Total | $1,395,942 |
Aggarwal received $575.1K in salary, accounting for 41% of the total pay in 2022.
Aggarwal also received $253K in non-equity incentive plan, $556.3K in option awards and $11.6K in other compensation.
Rankings
In 2022, Sumit Aggarwal's compensation ranked 2,385th out of 5,760 executives tracked by ExecPay. In other words, Aggarwal earned more than 58.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,385 out of 5,760 | 59th |
Division Manufacturing | 1,309 out of 3,136 | 58th |
Major group Chemicals And Allied Products | 583 out of 1,422 | 59th |
Industry group Drugs | 538 out of 1,323 | 59th |
Industry Biological Products, Except Diagnostic Substances | 131 out of 291 | 55th |
Source: SEC filing on April 28, 2023.
Aggarwal's colleagues
We found two more compensation records of executives who worked with Sumit Aggarwal at Sevion Therapeutics in 2022.